Daniel J Wall, MD in Corona Del Mar, CA - Medicare Dermatology

Daniel J Wall, MD is a medicare enrolled "Dermatology" physician in Corona Del Mar, California. He went to Rutgers, Robert Woood Johnson Medical School and graduated in 1997 and has 27 years of diverse experience with area of expertise as Dermatology. He is a member of the group practice Permanente Medical Group Inc and his current practice location is 2121 E Coast Hwy, Ste 250, Corona Del Mar, California. You can reach out to his office (for appointments etc.) via phone at (949) 721-6000.

Daniel J Wall is licensed to practice in California (license number A74764) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1508852013.

Contact Information

	Daniel J Wall, MD
	2121 E Coast Hwy, Ste 250, Corona Del Mar, CA 92625-1932
	(949) 721-6000
	(949) 721-6006

Physician's Profile

Full Name	Daniel J Wall
Gender	Male
Speciality	Dermatology
Experience	27 Years
Location	2121 E Coast Hwy, Corona Del Mar, California
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Daniel J Wall attended and graduated from Rutgers, Robert Woood Johnson Medical School in 1997

NPI Data:

NPI Number: 1508852013
Provider Enumeration Date: 09/21/2005
Last Update Date: 02/11/2022

Medicare PECOS Information:

PECOS PAC ID: 4789739608
Enrollment ID: I20090828000391

Medical Identifiers

Medical identifiers for Daniel J Wall such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1508852013	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207N00000X	Dermatology	A74764 (California)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Permanente Medical Group Inc	8921910225	7800

News Archive

Smokers taking the Respiragene test try to quit smoking, reveals study

Smokers who see their own personal risk of developing lung cancer after genetic-based testing show stronger intention and take more action on quitting smoking, according to clinical trial results presented to an American Association of Cancer Research conference.

Insurers will receive Presidential warning while administration to release regulations to protect consumers

President Obama will warn health insurance executives at a White House meeting Tuesday against trying to increase premium rates before the new law takes effect, The New York Times reports. "The White House is concerned that health insurers will blame the new law for increases in premiums that are intended to maximize profits rather than covering claims."

AseraCare publishes guide book on hospice

AseraCare Hospice, one of the nation's premier providers of hospice and palliative care services, has published Hospice: The Loving Circle of Care, a book that guides readers through the difficult process of deciding when to seek hospice. Hospice: The Loving Circle of Care helps hospice patients and their families as well as physicians and caregivers understand hospice and its benefits, while providing personal accounts of AseraCare patient experiences.

FDA gives clearance to IND application for Calibr's 'switchable' CAR-T cell therapy

Calibr, the drug discovery and development division of Scripps Research, today announced that the U.S. Food and Drug Administration has given clearance to the Investigational New Drug (IND) application for Calibr's "switchable" CAR-T cell therapy, which is being evaluated for the treatment of certain cancers, including relapsed/refractory B-cell malignancies such as non-Hodgkin lymphoma and chronic lymphocytic leukemia.

Phase Forward and Merck project wins the Society for Clinical Data Management Data Driven Innovation Award

Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced that a joint project with customer Merck & Co. has won the 2009 Society for Clinical Data Management (SCDM) Data Driven Innovation Award competition. This annual honor recognizes the year's best advancement in clinical data management technology or service.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Daniel J Wall allows following entities to bill medicare on his behalf.

Entity Name	Permanente Medical Group Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710

News Archive

Smokers taking the Respiragene test try to quit smoking, reveals study

Insurers will receive Presidential warning while administration to release regulations to protect consumers

AseraCare publishes guide book on hospice

FDA gives clearance to IND application for Calibr's 'switchable' CAR-T cell therapy

Phase Forward and Merck project wins the Society for Clinical Data Management Data Driven Innovation Award

Entity Name	Csi Medical Group
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1871909804 PECOS PAC ID: 5890916845 Enrollment ID: O20141016001930

Smokers taking the Respiragene test try to quit smoking, reveals study

Insurers will receive Presidential warning while administration to release regulations to protect consumers

AseraCare publishes guide book on hospice

FDA gives clearance to IND application for Calibr's 'switchable' CAR-T cell therapy

Phase Forward and Merck project wins the Society for Clinical Data Management Data Driven Innovation Award

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Daniel J Wall is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Daniel J Wall, MD 2121 E Coast Hwy, Ste 250, Corona Del Mar, CA 92625-1932 Ph: (925) 952-9003	Daniel J Wall, MD 2121 E Coast Hwy, Ste 250, Corona Del Mar, CA 92625-1932 Ph: (949) 721-6000

News Archive

Smokers taking the Respiragene test try to quit smoking, reveals study

Insurers will receive Presidential warning while administration to release regulations to protect consumers

AseraCare publishes guide book on hospice

FDA gives clearance to IND application for Calibr's 'switchable' CAR-T cell therapy

Phase Forward and Merck project wins the Society for Clinical Data Management Data Driven Innovation Award

Dermatology Doctors in Corona Del Mar, CA

Dr. Mark Minh Tran, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2121 E Coast Hwy Ste 110, Corona Del Mar, CA 92625 Phone: 949-629-4263 Fax: 949-629-4266
Dr. Lina Jacklyn Kennedy, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 2121 E Coast Hwy Ste 280, Corona Del Mar, CA 92625 Phone: 949-688-1288
Dr. Madeline Lois Miller, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 2600 E Coast Hwy, Suite 200, Corona Del Mar, CA 92625 Phone: 949-721-4161
Dr. Catherine Hee Yong Lee, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2121 E Coast Hwy Ste 110, Corona Del Mar, CA 92625 Phone: 949-629-4263 Fax: 949-629-4266

Daniel J Wall, MD - Medicare Dermatology in Corona Del Mar, CA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Smokers taking the Respiragene test try to quit smoking, reveals study

Insurers will receive Presidential warning while administration to release regulations to protect consumers

AseraCare publishes guide book on hospice

FDA gives clearance to IND application for Calibr's 'switchable' CAR-T cell therapy

Phase Forward and Merck project wins the Society for Clinical Data Management Data Driven Innovation Award

Medicare Reassignments

Smokers taking the Respiragene test try to quit smoking, reveals study

Insurers will receive Presidential warning while administration to release regulations to protect consumers

AseraCare publishes guide book on hospice

FDA gives clearance to IND application for Calibr's 'switchable' CAR-T cell therapy

Phase Forward and Merck project wins the Society for Clinical Data Management Data Driven Innovation Award

Smokers taking the Respiragene test try to quit smoking, reveals study

Insurers will receive Presidential warning while administration to release regulations to protect consumers

AseraCare publishes guide book on hospice

FDA gives clearance to IND application for Calibr's 'switchable' CAR-T cell therapy

Phase Forward and Merck project wins the Society for Clinical Data Management Data Driven Innovation Award

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Smokers taking the Respiragene test try to quit smoking, reveals study

Insurers will receive Presidential warning while administration to release regulations to protect consumers

AseraCare publishes guide book on hospice

FDA gives clearance to IND application for Calibr's 'switchable' CAR-T cell therapy

Phase Forward and Merck project wins the Society for Clinical Data Management Data Driven Innovation Award

Dermatology Doctors in Corona Del Mar, CA